EDA and cancer: In contrast to ED-A+ Fn, a variety of studies investigating ED-B+ Fn revealed that its re-expression is strongly linked to cancer development and tumour-associated angiogenesis and not to non-neoplastic chronic inflammatory diseases [39,40,41].